|
Acute Cardiac Dysfunction in Critical Illnes
RECRUITINGSponsored by Sahlgrenska University Hospital
Actively Recruiting
SponsorSahlgrenska University Hospital
Started2023-05-29
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05860504
Summary
The overall aim of the study is to establish the clinical importance of cardiac dysfunction, by estimating its incidence and impact on short- and long-term outcomes, in a mixed population of critically ill patients with multi-organ failure. Pathogenesis of cardiac dysfunction in critical illness and key molecules linked to this will be explored.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Patients aged \> 18 years 2. Admitted to a participating ICU within 24 hours 3. Significant organ dysfunction involving at least two organ systems. This is defined as fulfilling both of the following: * At least 4 points on the SOFA scale (Sequential Organ Failure Assessment scale) * Having at least 1 point on the SOFA scale from at least two organ systems 4. Given informed consent from patient or permission to participate from next of kin Exclusion Criteria: 1. Echocardiographic examination not possible (e.g., pneumothorax, draping etc) or very low echocardiographic examination quality 2. Not being examined with echocardiography within 24 hours from inclusion 3. Retracted consent to participate
Conditions7
Cardiomyopathy, StressHeart DiseaseLeft Ventricular DysfunctionMulti Organ FailureMyocardial InfarctionRight Ventricular DysfunctionTako Tsubo Cardiomyopathy
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSahlgrenska University Hospital
Started2023-05-29
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05860504